Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Retained Earnings (2021 - 2025)

Caribou Biosciences has reported Retained Earnings over the past 5 years, most recently at $103000.0 for Q4 2025.

  • Quarterly Retained Earnings fell 59.61% to $103000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103000.0 through Dec 2025, down 59.61% year-over-year, with the annual reading at $103000.0 for FY2025, 59.61% down from the prior year.
  • Retained Earnings was $103000.0 for Q4 2025 at Caribou Biosciences, up from -$570.0 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $789000.0 in Q3 2024 and troughed at -$570.0 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$58.3 million (2021), against an average of -$146.3 million.
  • Year-over-year, Retained Earnings soared 180.43% in 2024 and then crashed 169962.7% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$135000.0 in 2021, then crashed by 145985.19% to -$197.2 million in 2022, then tumbled by 51.76% to -$299.3 million in 2023, then surged by 100.09% to $255000.0 in 2024, then crashed by 59.61% to $103000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Retained Earnings are $103000.0 (Q4 2025), -$570.0 million (Q3 2025), and -$542.5 million (Q2 2025).